Indication
Epithelial
2 clinical trials
3 products
1 drug
Clinical trial
A Phase 1a, Dose Escalation, Safety and Tolerability Study of NX-1607, a Casitas B-lineage Lymphoma Proto-oncogene (CBL-B) Inhibitor, in Adults With Advanced Malignancies, With Phase 1b Expansion in Select Tumor TypesStatus: Recruiting, Estimated PCD: 2024-08-31
Product
NX-1607Drug
TiragolumabClinical trial
A Phase 1, First-in-Human, Dose-Finding and Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Activity of XmAb®808 in Combination With Pembrolizumab in Selected Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2027-12-01
Product
XmAb®808Product
Keytruda